Background: Chronic Spontaneous urticarial (CSU) is a common dermatological problem characterized by recurrent pruritic or burning wheals last less than 24 hours and treated many modalities of therapy including systemic antihistamines in refractory cases with Omalizumab anti-IgE antibody biological injection. Latent tuberculosis infection (LTBI) diagnosed based on positive tuberculin skin test ...

Chronic spontaneous urticaria (CSU) is a common and challenging disease, especially with respect to healthcare provision in the context of the German statutory health insurance system. If treatment with second-generation antihistamines is unsuccessful, current guidelines recommend further therapeutic options. However, most of these are off-label. This discrepancy between treatment according to ...

Background Omalizumab is the recommended treatment for antihistamine-refractory chronic spontaneous urticaria (CSU) and severe allergic asthma. In addition, it has been shown to reduce frequency of viral respiratory infections in Respiratory illness a known trigger asthma CSU. Objectives To explore whether antiviral effect omalizumab may be extended CSU patients independent their atopic status....

The CSU Face Identification Evaluation System provides standard face recognition algorithms and standard statistical methods for comparing face recognition algorithms. This document describes Version 4.0 the Colorado State University (CSU) Face Identification Evaluation System. The system includes standardized image pre-processing software, three distinct face recognition algorithms, analysis s...

Zusammenfassung Welche Bedeutung messen die Landesparteien der Waldpolitik bei? Waldfunktionen priorisieren sie? Inwieweit sind ihre Positionen von Parteiendifferenzen geprägt? Um diese Forschungsfragen zu adressieren, führen wir eine textanalytische Auswertung Landtagswahlprogrammen durch, im Zeitraum 1990 bis 2019 veröffentlicht wurden. Unsere Analysen zeigen, dass Parteien nicht nur vom regi...

BACKGROUND The X-ACT study aimed to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H1 -antihistamines. METHODS In X-ACT, a phase III, double-blind, placebo-controlled study, CSU patients (18-75 years) with ≥4 angioedema episodes during the 6 months before inclusion were randomized ...